(19)

(11)

EP 4 580 600 A1

(12)

(43) Date of publication: 09.07.2025 Bulletin 2025/28 (21) Application number: 23765459.5 (22) Date of filing: 01.09.2023

(51) International Patent Classification (IPC):  A61K 9/00(2006.01) A61K 47/02(2006.01) A61K 31/5383(2006.01) A61K 9/06(2006.01) A61K 31/573(2006.01) A61P 27/02(2006.01) (52) Cooperative Patent Classification (CPC): A61K 9/0048; A61K 9/06; A61K 47/02; A61K 31/573; A61K 31/5383; A61P 27/02 (86) International application number: PCT/EP2023/074034 (87) International publication number: WO 2024/047230 (07.03.2024 Gazette 2024/10)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 01.09.2022 FI 20225766 (71) Applicant: Optifye Therapeutics AG 6340 Baar (CH)	(72) Inventors: VAAHTIO, Minna 20740 Turku (FI) LEINO, Lasse 21160 Masku (FI) KAIMAINEN, Mika 21200 Raisio (FI) (74) Representative: Nederlandsch Octrooibureau  P.O. Box 29720 2502 LS The Hague 2502 LS The Hague (NL)